Toronto General Hospital Research Institute, University Health Network, Toronto, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Clin Sci (Lond). 2021 May 28;135(10):1295-1309. doi: 10.1042/CS20200963.
Aortic macrophage accumulation is characteristic of the pathogenesis of abdominal aortic aneurysm (AAA) but the mechanisms of macrophage accumulation and their phenotype are poorly understood. Lymphatic vessel endothelial receptor-1 (Lyve-1+) resident aortic macrophages independently self-renew and are functionally distinct from monocyte-derived macrophages recruited during inflammation. We hypothesized that Lyve-1+ and Lyve-1- macrophages differentially contribute to aortic aneurysm. Approach and results: Angiotensin-2 and β-aminopropionitrile (AT2/BAPN) were administered to induce AAA in C57BL/6J mice. Using immunohistochemistry (IHC), we demonstrated primarily adventitial accumulation of aortic macrophages, and in association with areas of elastin fragmentation and aortic dissection. Compared with controls, AAA was associated with a relative percent depletion of Lyve-1+ resident aortic macrophages and accumulation of Lyve-1- macrophages. Using CD45.1/CD45.2 parabiosis, we demonstrated aortic macrophage recruitment in AAA. Depletion of aortic macrophages in CCR2-/- mice was associated with reduced aortic dilatation indicating the functional role of recruitment from the bone marrow. Depletion of aortic macrophages using anti-macrophage colony-stimulating factor 1 receptor (MCSF1R)-neutralizing antibody (Ab) reduced the incidence of AAA. Conditional depletion of Lyve-1+ aortic macrophages was achieved by generating Lyve-1wt/cre Csf1rfl/fl mice. Selective depletion of Lyve-1+ aortic macrophages had no protective effects following AT2/BAPN administration and resulted in increased aortic dilatation in the suprarenal aorta.
Aortic macrophage accumulation in AAA derives from adventitial recruitment of Lyve-1- macrophages, with relative percent depletion of Lyve-1+ macrophages. Selective targeting of macrophage subtypes represents a potential novel therapeutic avenue for the medical treatment of AAA.
腹主动脉瘤(AAA)发病机制的一个特征是主动脉巨噬细胞的积累,但巨噬细胞的积累机制及其表型仍知之甚少。淋巴管内皮受体 1(Lyve-1+)驻留的主动脉巨噬细胞独立地自我更新,并且与炎症期间募集的单核细胞衍生的巨噬细胞在功能上不同。我们假设 Lyve-1+和 Lyve-1-巨噬细胞对主动脉瘤有不同的贡献。
血管紧张素-2 和β-氨基丙腈(AT2/BAPN)给药以诱导 C57BL/6J 小鼠发生 AAA。通过免疫组织化学(IHC),我们证明了主动脉巨噬细胞主要积累在 adventitia,与弹性蛋白片段化和主动脉夹层区域相关。与对照组相比,AAA 与 Lyve-1+驻留的主动脉巨噬细胞相对百分比耗竭和 Lyve-1-巨噬细胞积累相关。使用 CD45.1/CD45.2 联体共生,我们证明了 AAA 中主动脉巨噬细胞的募集。CCR2-/-小鼠中主动脉巨噬细胞的耗竭与主动脉扩张减少有关,表明从骨髓招募的功能作用。使用抗巨噬细胞集落刺激因子 1 受体(MCSF1R)中和抗体(Ab)耗竭主动脉巨噬细胞可减少 AAA 的发生率。通过生成 Lyve-1wt/cre Csf1rfl/fl 小鼠实现 Lyve-1+主动脉巨噬细胞的条件性耗竭。在 AT2/BAPN 给药后,Lyve-1+主动脉巨噬细胞的选择性耗竭没有保护作用,并且导致肾上腺上主动脉的扩张增加。
AAA 中的主动脉巨噬细胞积累来自 Lyve-1-巨噬细胞的 adventitial 募集,Lyve-1+巨噬细胞的相对百分比耗竭。针对巨噬细胞亚型的选择性靶向可能是 AAA 医学治疗的一种潜在新的治疗途径。